ATCC Announces New Appointments to its Leadership Team
Positions focus on driving business growth
Manassas, VA, United StatesSeptember 28, 2017
ATCC, a global leader in biological materials management and standards, today announced two appointments to the senior leadership team. Mr. Daniel Kelly joins ATCC as Chief Information and Technology Officer (CITO), and Mr. John Sweeney joins as Chief Financial Officer (CFO).
As CITO, Mr. Kelly will develop and drive information and technology strategies that sustain ATCC’s current mission as well as extend our reach into new technology-based business opportunities. Mr. Kelly brings more than 30 years of progressive experience in management consulting, IT professional services, IT management, and operations management. Prior to joining ATCC, Mr. Kelly was Chief Information Officer at Parsons Infrastructure, and held executive leadership roles at organizations such as MedRisk, Apria Healthcare, and Perot Systems. Mr. Kelly is a graduate of Siena College in Loudonville, New York, where he earned his Bachelor’s Degree in Marketing/Marketing Management.
As CFO, Mr. Sweeney will oversee finance and accounting and other corporate matters and will work with the ATCC executive leadership team to explore a wide range of new initiatives that both advance our mission and aid in the diversification of opportunities.
Mr. Sweeney has over twenty years of experience in the pharmaceutical and life sciences sector. Prior to joining ATCC, Mr. Sweeney was Vice President of Finance for the US Division of Alvogen Group, and held leadership roles in organizations including Actavis and Purdue Pharma. Mr. Sweeney is a Certified Public Accountant and earned his Bachelor’s Degree in Accounting at Western Connecticut State University and his MBA from the Stern School of Business at New York University.
“We are excited to have Dan and John on the leadership team,” said Dr. Raymond H. Cypess, ATCC Chairman and CEO. “Dan is an accomplished and innovative information technology executive with extensive experience across multiple commercial and public market sectors. John brings a wide range of experience to ATCC as both a finance and business leader in the life sciences, with expertise in financial analysis, budgeting, cash management, and acquisitions, as well as a strong technical accounting background”. Dr. Cypess added, “both executives bring new skills and perspectives to ATCC and are poised to align well with our go-forward growth strategy.”
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, and people provide the scientific community with credible biological products, advanced model systems, and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a non-profit organization with headquarters in Manassas, VA, and an R&D innovation center in Gaithersburg, MD.
Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, 703-365-2700 ext. 2753